4//SEC Filing
Glanzman Robert 4
Accession 0001562180-22-001501
CIK 0001822791other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 9:02 AM ET
Size
5.8 KB
Accession
0001562180-22-001501
Insider Transaction Report
Form 4
Clene Inc.CLNN
Glanzman Robert
Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2022-02-15+140,000→ 140,000 totalExercise: $3.04Exp: 2032-02-15→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 15, 2022 as an option for 140,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.04 per share. The options vest with respect to the first 25% of such shares on February 15, 2023 and then in 36 equal installments of the balance of the shares of Common Stock on the 15th day of each calendar month thereafter beginning March 15, 2023 until such shares are fully vested.
Documents
Issuer
Clene Inc.
CIK 0001822791
Entity typeother
Related Parties
1- filerCIK 0001835428
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 9:02 AM ET
- Size
- 5.8 KB